XM does not provide services to residents of the United States of America.

Auto, pharma drag Indian shares as earnings, foreign outflows weigh



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>INDIA STOCKS-Auto, pharma drag Indian shares as earnings, foreign outflows weigh</title></head><body>

Updates at 10:08 a.m. IST

By Bharath Rajeswaran

Oct 29 (Reuters) -Indian shares fell on Tuesday, weighed down by auto and pharma stocks, while caution prevailed due to a largely tepid earnings season and persistent foreign selling.

The NSE Nifty 50 .NSEI was down 0.55% to 24,207.38 points as of 10:08 a.m. IST, while BSE Sensex .BSESN lost 0.48% to 79,620.97, after snapping a six-session losing streak on Monday.

The broader, more domestically-focused small- .NIFSMCP100 and mid-caps .NIFMDCP100 remained flat.

"While markets started the week on a positive note, caution prevails due to the upcoming U.S jobs data, uncertainty over the presidential election, a largely tepid domestic earnings season and heavy foreign outflows," said Prashanth Tapse, senior vice president of research at Mehta Equities.

The Nifty 50 has dropped about 7% from a record high hit on Sept. 27, weighed by foreign outflows over the last 21 sessions.

Eight of the 13 major sectors logged losses, with auto stocks .NIFTYAUTO down 2% to be the top sectoral loser by percentage.

All the 15 stocks in the index declined. Mahindra & Mahindra MAHM.NS fell 2% on multiple block deals at a discount to its last close.

Maruti Suzuki India MRTI.NS also lost 2% ahead of its results later in the day.

Meanwhile, the pharma index .NIPHARM lost 1.8%.

Torrent Pharma fell 3%, extending its post-results drop to 6%, while Cipla CIPL.NS shed 3.3% ahead of its quarterly results later in the day.

Among individual stocks, telecom operator Bharti Airtel BRTI.NS lost 2.7% after reporting a smaller-than-expected second quarter-profit on Monday.

State-owned refiner IndianOil Corp IOC.NS lost 3% after posting a drop in September-quarter profit.

Non-bank lender Spandana Sphoorty SPAD.NS lost 13% after reporting a loss for the September-quarter.

On the flip side, FederalBank FED.NS gained 6.1% after posting a rise in quarterly profit and was the top gainer in the Nifty bank index .NSEBANK, which rose 0.2%.



Reporting by Bharath Rajeswaran in Bengaluru; Editing by Rashmi Aich, Janane Venkatraman and Varun H K

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.